Bio-Rad Laboratories (BIO) Assets Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bio-Rad Laboratories | 8.23 Bn | 6.66 Bn | 309.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.81% |
| Dec 31, 2025 | 92.40% |
| Sep 30, 2025 | -4.21% |
| Jun 30, 2025 | 0.23% |
| Mar 31, 2025 | -48.71% |
| Dec 31, 2024 | 3.18% |
| Mar 31, 2024 | -46.83% |
| Dec 31, 2023 | -86.02% |
| Sep 30, 2023 | 12.10% |
| Jun 30, 2023 | 13.40% |
| Mar 31, 2023 | 17.07% |
| Dec 31, 2022 | -83.04% |
| Sep 30, 2022 | 23.57% |
| Jun 30, 2022 | 25.07% |
| Mar 31, 2022 | 29.46% |
| Dec 31, 2021 | -44.23% |
| Sep 30, 2021 | 37.77% |
| Jun 30, 2021 | 31.30% |
| Mar 31, 2021 | 29.99% |
| Dec 31, 2020 | -35.91% |
| Sep 30, 2020 | 26.81% |
| Jun 30, 2020 | 23.42% |
| Mar 31, 2020 | 21.16% |
| Dec 31, 2019 | 19.11% |
| Sep 30, 2019 | 16.21% |
| Jun 30, 2019 | 17.14% |
| Mar 31, 2019 | 14.80% |
| Dec 31, 2018 | 10.61% |
| Sep 30, 2018 | 15.42% |
| Jun 30, 2018 | 12.89% |
| Mar 31, 2018 | 12.45% |
| Dec 31, 2017 | 4.41% |
| Sep 30, 2017 | 4.85% |
| Jun 30, 2017 | 5.51% |
| Mar 31, 2017 | 4.40% |
| Dec 31, 2016 | 4.45% |
| Sep 30, 2016 | 6.24% |
| Jun 30, 2016 | 4.94% |
| Mar 31, 2016 | 5.23% |
| Dec 31, 2015 | 3.91% |
| Sep 30, 2015 | 6.45% |
| Jun 30, 2015 | 6.88% |
| Dec 31, 2014 | 5.67% |